Determinants of Nitric Oxide Chemistry. Impact of Cell Signaling Processes.

Nitric Oxide

Volumn , Issue , 2010, Pages 3-25

  Thomas, Douglas D ^a   Flores Santana, Wilmarie ^b   Switzer, Christopher H ^b   Wink, David A ^b   Ridnour, Lisa A ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Nitric oxide; Nitrosative stress; Oxidative

Indexed keywords

EID: 84882529570     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-373866-0.00001-0     Document Type: Chapter

References (118)

1. Abu-Soud H.M., Hazen S.L. Nitric oxide is a physiological substrate for mammalian peroxidases. J. Biol. Chem. 2000, 275:37524-37532.
2. Abu-Soud H.M., Rousseau D.L., Stuehr D.J. Nitric oxide binding to the heme of neuronal nitric-oxide synthase links its activity to changes in oxygen tension. J. Biol. Chem. 1996, 271:32515-32518.
3. Borutaite V., Brown G.C. S-nitrosothiol inhibition of mitochondrial complex I causes a reversible increase in mitochondrial hydrogen peroxide production. Biochim. Biophys. Acta. 2006, 1757:562-566.
4. Bove P.F., Wesley U.V., Greul A.K., Hristova M., Dostmann W.R., van d.V.A. Nitric oxide promotes airway epithelial wound repair through enhanced activation of MMP-9. Am. J. Respir. Cell. Mol. Biol. 2007, 36:138-146.
5. Brahimi-Horn M.C., Pouyssegur J. Harnessing the hypoxia-inducible factor in cancer and ischemic disease. Biochem. Pharmacol. 2007, 73:450-457.
6. Bredt D.S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic. Res. 1999, 31:577-596.
7. Brune B. The intimate relation between nitric oxide and superoxide in apoptosis and cell survival. Antioxid Redox Signal 2005, 7:497-507.
8. Buerk D.G. Nitric oxide regulation of microvascular oxygen. Antioxid Redox Signal 2007, 9:829-843.
9. Carcillo J.A., Doughty L., Kofos D., Frye R.F., Kaplan S.S., Sasser H., Burckart G.J. Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure. Intensive Care Med 2003, 29:980-984.
10. Cardounel A.J., Xia Y., Zweier J.L. Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase: differences in the effects of monomethyl- and dimethylarginines in the presence and absence of tetrahydrobiopterin. J. Biol. Chem. 2005, 280:7540-7549.
11. Chang C., Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol. 2001, 11:S37-S43.
12. Chen X., Buerk D.G., Barbee K.A., Jaron D. A model of NO/O2 transport in capillary-perfused tissue containing an arteriole and venule pair. Ann Biomed. Eng. 2007, 35:517-529.
13. Chen Y.Y., Huang Y.F., Khoo K.H., Meng T.C. Mass spectrometry-based analyses for identifying and characterizing S-nitrosylation of protein tyrosine phosphatases. Methods 2007, 42:243-249.
14. Cheng J.J., Wung B.S., Chao Y.J., Wang D.L. Tsao Cyclic strain-induced reactive oxygen species involved in ICAM-1 gene induction in endothelial cells. Hypertension 1998, 31:125-130.
15. Chong Z.Z., Li F., Maiese K. Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury. Histol. Histopathol. 2005, 20:299-315.
16. Cleeter M.W., Cooper J.M., Darley-Usmar V.M., Moncada S., Schapira A.H. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett. 1994, 345:50-54.
17. Connelly L., Jacobs A.T., Palacios-Callender M., Moncada S., Hobbs A.J. Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression. J. Biol. Chem. 2003, 278:26480-26487.
18. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
19. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998, 391:393-397.
20. Espey M.G., Miranda K.M., Pluta R.M., Wink D.A. Nitrosative capacity of macrophages is dependent on nitric-oxide synthase induction signals. J. Biol. Chem. 2000, 275:11341-11347.
21. Espey M.G., Miranda K.M., Thomas D.D., Wink D.A. Distinction between nitrosating mechanisms within human cells and aqueous solution. J. Biol. Chem. 2001, 276:30085-30091.
22. Espey M.G., Thomas D.D., Miranda K.M., Wink D.A. Focusing of nitric oxide mediated nitrosation and oxidative nitrosylation as a consequence of reaction with superoxide. Proc. Natl. Acad. Sci. USA 2002, 99:11127-11132.
23. Espey M.G., Xavier S., Thomas D.D., Miranda K.M., Wink D.A. Direct real-time evaluation of nitration with green fluorescent protein in solution and within human cells reveals the impact of nitrogen dioxide vs. peroxynitrite mechanisms. Proc. Natl. Acad. Sci. USA 2002, 99:3481-3486.
24. Ford E., Hughes M.N., Wardman P. Kinetics of the reactions of nitrogen dioxide with glutathione, cysteine, and uric acid at physiological pH. Free Radic. Biol. Med. 2002, 32:1314-1323.
25. Ford P.C., Wink D.A., Stanbury D.M. Autooxidation kinetics of aqueous nitric oxide. FEBS Lett. 1993, 326:1-3.
26. Forman H.J. Use and abuse of exogenous H2O2 in studies of signal transduction. Free Radic. Biol. Med. 2007, 42:926-932.
27. Forman H.J., Torres M., Fukuto J. Redox signaling. Mol. Cell. Biochem. 2002, 234-235:49-62.
28. Fu X., Kao J.L., Bergt C., Kassim S.Y., Huq N.P., d'Avignon A., Parks W.C., Mecham R.P., Heinecke J.W. Oxidative cross-linking of tryptophan to glycine restrains matrix metalloproteinase activity: specific structural motifs control protein oxidation. J. Biol. Chem. 2004, 279:6209-6212.
29. Fu X., Kassim S.Y., Parks W.C., Heinecke J.W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J. Biol. Chem. 2001, 276:41279-41287.
30. Fu X., Kassim S.Y., Parks W.C., Heinecke J.W. Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation. J. Biol. Chem. 2003, 278:28403-28409.
31. Fulton D., Gratton J.P., Sessa W.C. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?. J. Pharmacol. Exp. Ther. 2001, 299:818-824.
32. Galijasevic S., Saed G.M., Diamond M.P., Abu-Soud H.M. Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition. Proc. Natl. Acad. Sci. USA 2003, 100:14766-14771.
33. Gaston B., Reilly J., Drazen J.M., Fackler J., Ramdev P., Arnelle D., Mullins M.E., Sugarbaker D.J., Chee C., Singel D.J., Loscalzo J., Stamler J.S. Endogenous nitrogen oxides and bronchodilator S-nitosothiols in human airways. Proc. Natl. Acad. Sci. USA 1993, 90:10957-10961.
34. Gbadegesin M., Vicini S., Hewett S.J., Wink D.A., Espey M., Pluta R.M., Colton C.A. Hypoxia modulates nitric oxide-induced regulation of NMDA receptor currents and neuronal cell death. Am. J. Physiol. 1999, 277:C673-C683.
35. Ghosh D.K., Salerno J.C. Nitric oxide synthases: domain structure and alignment in enzyme function and control. Front. Biosci. 2003, 8:d193-d209.
36. Halliwell B., Gutteridge J.M.C. Protection against oxidants in biological systems: the superoxide theory of oxygen toxicity. Free Radicals in Biology and Medicine 1989, 86-178. Oxford University Press. 2nd edn.
37. Hanbauer I., Cox G.W., Wink D.A. Synaptic and extrasynaptic action of free radicals on cell-to-cell signaling. Ann. N. Y. Acad. Sci. 1994, 738:173-180.
38. Hofseth L.J., Saito S., Hussain S.P., Espey M.G., Miranda K.M., Araki Y., Jhappan C., Higashimoto Y., He P., Linke S.P., Quezado M.M., Zurer I., Rotter V., Wink D.A., Appella E., Harris C.C. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci U. S. A 2003, 100:143-148.
39. Hori K., Burd P.R., Furuke K., Kutza J., Weih K.A., Clouse K.A. Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: astrocytic NO as a possible mediator of neural damage in acquired immunodeficiency syndrome. Blood 1999, 93:1843-1850.
40. Hussain S.P., Hofseth L.J., Harris C.C. Radical causes of cancer. Nat. Rev. Cancer 2003, 3:276-285.
41. Isenberg J.S., Ridnour L.A., Perruccio E.M., Espey M.G., Wink D.A., Roberts D.D. Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13141-13146.
42. Isenberg J.S., Ridnour L.A., Thomas D.D., Wink D.A., Roberts D.D., Espey M.G. Guanylyl cyclase-dependent chemotaxis of endothelial cells in response to nitric oxide gradients. Free Radic. Biol. Med. 2006, 40:1028-1033.
43. Kassim S.Y., Fu X., Liles W.C., Shapiro S.D., Parks W.C., Heinecke J.W. NADPH oxidase restrains the matrix metalloproteinase activity of macrophages. J. Biol. Chem. 2005, 280:30201-30205.
44. Kim S.F., Huri D.A., Snyder S.H. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 2005, 310:1966-1970.
45. Koesling D., Russwurm M., Mergia E., Mullershausen F., Friebe A. Nitric oxide-sensitive guanylyl cyclase: structure and regulation. Neurochem. Int. 2004, 45:813-819.
46. Koppenol W.H. Chemistry of peroxynitrite and its relevance to biological systems. Met. Ions. Biol. Syst. 1999, 597-619.
47. Kubes P., Kanwar S., Niu X.F., Gaboury J.P. Nitric oxide inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 1993, 264:G143-G149.
48. Lamkin-Kennard K.A., Buerk D.G., Jaron D. Interactions between NO and O2 in the microcirculation: a mathematical analysis. Microvasc. Res. 2004, 68:38-50.
49. Lancaster J. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc. Natl. Acad. Sci. U. S. A 1994, 91:8137-8141.
50. Lancaster J.R.J. Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions. Chem. Res. Toxicol. 2006, 19:1160-1174.
51. Lee S.H., Lee S.M. Suppression of hepatic cytochrome p450-mediated drug metabolism during the late stage of sepsis in rats. Shock 2005, 23:144-149.
52. Lipton S.A., Choi Y.B., Pan Z.H., Lel S.Z., Chen H.S., Sucker N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotection and neurodestruction effects of nitric oxide and related nitroso-compounds. Nature 1993, 364:626-632.
53. Liu R.H., Hotchkiss J.H. Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat. Res. 1995, 339:73-89.
54. Liu X., Miller M.J.S., Joshi M.S., Thomas D.D., Lancaster J.R.J. Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc. Natl. Acad. Sci. U. S. A 1998, 95:2175-2179.
55. Lymar S.V., Hurst K. Rapid reaction between peroxynitrite ion and cabon dioxide: implications for biological activity. J. Am. Chem. Soc. 1995, 290:52-57.
56. Marletta M.A. Mammalian synthesis of nitrite, nitrate, nitric oxide and N-nitrosating agents. Chem. Res. Toxicol. 1988, 1:249-257.
57. Mason M.G., Nicholls P., Wilson M.T., Cooper C.E. Nitric oxide inhibition of respiration involves both competitive (heme) and noncompetitive (copper) binding to cytochrome c oxidase. Proc. Natl. Acad. Sci. U. S. A 2006, 103:708-713.
58. Mirvish S.S. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett. 1995, 93:17-48.
59. Moller M.N., Li Q., Vitturi D.A., Robinson J.M., Lancaster J.R.J., Denicola A. Membrane "lens" effect: focusing the formation of reactive nitrogen oxides from the NO/O2 reaction. Chem. Res. Toxicol. 2007, 20:709-714.
60. Morris S.M.J. Recent advances in arginine metabolism. Curr. Opin. Clin. Nutr. Metab. Care 2004, 7:45-51.
61. Morris S.M.J. Arginine metabolism in vascular biology and disease. Vasc. Med. 2005, 10(1 Suppl):S83-S87.
62. Morris S.M.J. Arginine metabolism: boundaries of our knowledge. J. Nutr. 2007, 137:1602S-1609S.
63. Muller C.M., Scierka A., Stiller R.L., Kim Y.M., Cook D.R., Lancaster J.R.J., Buffington C.W., Watkins W.D. Nitric oxide mediates hepatic cytochrome P450 dysfunction induced by endotoxin. Anesthesiology 1996, 84:1435-1442.
64. Nelson K.K., Melendez J.A. Mitochondrial redox control of matrix metalloproteinases. Free Radic. Biol. Med. 2004, 37:768-784.
65. Ogawa R., Pacelli R., Espey M.G., Miranda K.M., Friedman N., Kim S.M., Cox G., Mitchell J.B., Wink D.A., Russo A. Comparison of control of Listeria by nitric oxide redox chemistry from murine macrophages and NO donors: insights into listeriocidal activity of oxidative and nitrosative stress. Free Radic. Biol. Med. 2001, 30:268-276.
66. Okamoto T., Akuta T., Tamura F., van D.V.A., Akaike T. Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation. Biol. Chem. 2004, 385:997-1006.
67. Parks W.C. Matrix metalloproteinases in repair. Wound Repair Regen. 1999, 7:423-432.
68. Peppin G.J., Weiss S.J. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc. Natl. Acad. Sci. U. S. A 1986, 83:4322-4326.
69. Pervin S., Singh R., Freije W.A., Chaudhuri G. MKP-1-induced dephosphorylation of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: implications in breast cancer. Cancer Res. 2003, 63:8853-8860.
70. Pervin S., Singh R., Hernandez E., Wu G., Chaudhuri G. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway. Cancer Res. 2007, 67:289-299.
71. Pfeiffer S., Lass A., Schmidt K., Mayer B. Protein tyrosine nitration in mouse peritoneal macrophages activated in vitro and in vivo: evidence against an essential role of peroxynitrite. FASEB J. 2001, 15:2355-2364.
72. Pfeiffer S., Lass A., Schmidt K., Mayer B. Protein tyrosine nitration in cytokine-activated murine macrophages. Involvement of a peroxidase/nitrite pathway rather than peroxynitrite. J. Biol. Chem. 2001, 276:34051-34058.
73. Pou S., Tsai P., Porasuphatan S., Halpern H.J., Chandramouli G.V., Barth E.D., Rosen G.M. Spin trapping of nitric oxide by ferro-chelates: kinetic and in vivo pharmacokinetic studies. Biochim. Biophys. Acta. 1999, 19:216-226.
74. Prueitt R.L., Boersma B.J., Howe T.M., Goodman J.E., Thomas D.D., Ying L., Pfiester C.M., Yfantis H.G., Cottrell J.R., Lee D.H., Remaley A.T., Hofseth L.J., Wink D.A., Ambs S. Inflammation and IGF-I activate the Akt pathway in breast cancer. Int. J. Cancer 2007, 120:796-805.
75. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peoxynitrite oxidation of sulfhydryls: The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 1991, 266:4244-4250.
76. Ridnour L.A., Isenberg J.S., Espey M.G., Thomas D.D., Roberts D.D., Wink D.A. Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc. Natl. Acad. Sci. U. S. A 2005, 102:13147-13152.
77. Ridnour L.A., Thomas D.D., Mancardi D., Espey M.G., Miranda K.M., Paolocci N., Feelisch M., Fukuto J., Wink D.A. The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations. Biol. Chem. 2004, 385:1-10.
78. Ridnour L.A., Windhausen A.N., Isenberg J.S., Yeung N., Thomas D.D., Vitek M.P., Roberts D.D., Wink D.A. Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways. Proc. Natl. Acad. Sci. U. S. A 2007, 104:16898-16903.
79. Saenz D.A., Bari S.E., Salido E., Chianelli M., Rosenstein R.E. Effect of nitroxyl on the hamster retinal nitridergic pathway. Neurochem. Int. 2007, 51:424-432.
80. Schindler H., Lutz M.B., Rollinghoff M., Bogdan C. The production of IFN-gamma by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4. J. Immunol. 2001, 166:3075-3082.
81. Schwartz S.E., White W.H. Trace Atmospheric Constituents: Properties, Transformation and Fates 1983, 1-117. John Wiley, New York. S.E. Schwartz (Ed.).
82. Shiva S., Oh J.Y., Landar A.L., Ulasova E., Venkatraman A., Bailey S.M., Darley-Usmar V.M. Nitroxia: the pathological consequence of dysfunction in the nitric oxide-cytochrome c oxidase signaling pathway. Free Radic. Biol. Med. 2005, 38:297-306.
83. Siwik D.A., Colucci W.S. Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail. Rev. 2004, 9:43-51.
84. Snyder G.D., Holmes R.W., Bates J.N., Van V.B.J. Nitric oxide inhibits aromatase activity: mechanisms of action. J. Steroid. Biochem. Mol. Biol. 1996, 58:63-69.
85. Stadler J., Harbrecht B.G., Di Silvio M., Curran R.D., Jordan M.L., Simmons R.L., Billiar T.R. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J. Leukoc. Biol. 1993, 53:165-172.
86. Stadler J., Trockfeld J., Schmalix W.A., Brill T., Siewert J.R., Greim H., Doehmer J. Inhibition of cytochromes P4501A by nitric oxide. Proc. Natl. Acad. Sci. U. S. A 1994, 91:3559-3563.
87. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 2001, 17:463-516.
88. Stuehr D.J. Structure-function aspects in the nitric oxide synthases. Annu. Rev. Pharmacol. Toxicol. 1997, 37:339-359.
89. Stuehr D.J., Santolini J., Wang Z.Q., Wei C.C., Adak S. Update on mechanism and catalytic regulation in the NO synthases. J. Biol. Chem. 2004, 279:36167-36170.
90. Takemura S., Minamiyama Y., Imaoka S., Funae Y., Hirohashi K., Inoue M., Kinoshita H. Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia. J. Hepatol. 1999, 30:1035-1044.
91. Tarpey M.M., Wink D.A., Grisham M.B. Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286:R431-R444.
92. Thom S.R., Fisher D., Zhang J., Bhopale V.M., Cameron B., Buerk D.G. Neuronal nitric oxide synthase and N-methyl-D-aspartate neurons in experimental carbon monoxide poisoning. Toxicol. Appl. Pharmacol. 2004, 194:280-295.
93. Thomas D.D., Espey M.G., Pociask D.A., Ridnour L.A., Donzelli S., Wink D.A. Asbestos redirects nitric oxide signaling through rapid catalytic conversion to nitrite. Cancer Res. 2006, 66:11600-11604.
94. Thomas D.D., Espey M.G., Ridnour L.A., Hofseth L.J., Mancardi D., Harris C.C., Wink D.A. Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Proc. Natl. Acad. Sci. U. S. A 2004, 101:8894-8899.
95. Thomas D.D., Espey M.G., Vitek M.P., Miranda K.M., Wink D.A. Protein nitration is mediated by heme and free metals through Fenton-type chemistry: an alternative to the NO/O2- reaction. Proc. Natl. Acad. Sci. U. S. A 2002, 99:12691-12696.
96. Thomas D.D., Liu X., Kantrow S.P., Lancaster J.R. The biological lifetime of nitric oxide: Implications for the perivascular dynamics of NO and O2. Proc. Natl. Acad. Sci. U. S. A 2001, 98:355-360.
97. Thomas D.D., Ridnour L.A., Espey M.G., Donzelli S., Ambs S., Hussain S.P., Harris C.C., DeGraff W., Roberts D.D., Mitchell J.B., Wink D.A. Superoxide fluxes limit nitric oxide-induced signaling. J. Biol. Chem. 2006, 281:25984-25993.
98. Tran C.T., Leiper J.M., Vallance P. The DDAH/ADMA/NOS pathway. Atheroscler. Suppl. 2003, 4:33-40.
99. Tsao P.S., Wang B., Buitrago R., Shyy J.Y., Cooke J.P. nitric oxide regulates monocyte chemotactic protein-1. Circulation 1997, 96:934-940.
100. Tunctan B., Yaghini F.A., Estes A., Malik K.U. Inhibition by nitric oxide of cytochrome P450 4A activity contributes to endotoxin-induced hypotension in rats. Nitric. Oxide 2006, 14:51-57.
101. Turpaev K., Bouton C., Drapier J.C. Nitric oxide-derived nitrosating species and gene expression in human monocytic cells. Biochemistry 2004, 43:10844-10850.
102. Vasquez-Vivar J., Hogg N., Martasek P., Karoui H., Pritchard K.A.J., Kalyanaraman B. Tetrahydrobiopterin-dependent inhibition of superoxide generation from neuronal nitric oxide synthase. J. Biol. Chem. 1999, 274:26736-26742.
103. Vasquez-Vivar J., Kalyanaraman B., Martasek P., Hogg N., Masters B.S., Karoui H., Tordo P., Pritchard K.A.J. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. U. S. A 1998, 95:9220-9225.
104. Vaughn M.W., Kuo L., Liao J.C. Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model. Am. J. Physiol. 1998, 274:H2163-H2176.
105. Vaughn M.W., Kuo L., Liao J.C. Effective diffusion distance of nitric oxide in the microcirculation. Am. J. Physiol. 1998, 274:H1705-H1714.
106. Vodovotz Y., Chesler L., Chong H., Kim S.J., Simpson J.T., DeGraff W., Cox G.W., Roberts A.B., Wink D.A., Barcellos-Hoff M.H. Regulation of transforming growth factor beta1 by nitric oxide. Cancer Res. 1999, 59:2142-2149.
107. Vodovotz Y., Kwon N., Popischil M., Manning J., Paik J., Nathan C. Inactivation of nitric oxide synthase following prolonged incubation of mouse macrophages with interferon-gamma and bacterial lipopolysaccharide. J. Immunol. 1994, 152:4110-4118.
108. Vukosavljevic N., Jaron D., Barbee K.A., Buerk D.G. Quantifying the L-arginine paradox in vivo. Microvasc. Res. 2006, 71:48-54.
109. Wang Y., Rosen H., Madtes D.K., Shao B., Martin T.R., Heinecke J.W., Fu X. Myeloperoxidase Inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation. J. Biol. Chem. 2007, 282:31826-31834.
110. Wink D.A. Ion implicated in blood pact. Nat. Med. 2003, 9:1460-1461.
111. Wink D.A., Mitchell J.B. The chemical biology of nitric oxide: insights into regulatory, cytotoxic and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 1998, 25:434-456.
112. Wink D.A., Miranda K.M., MG E., Pluta R.M., Hewett S.J., Colton C., Vitek M., Feelisch M., Grisham M.B. Mechanisms of the antioxidant effects of nitric oxide. Antioxid. Redox. Signal. 2001, 3:203-213.
113. Wink D.A., Nims R.W., Darbyshire J.F., Christodoulou D., Hanbauer I., Cox G.W., Laval F., Laval J., Cook J.A., Krishna M.C., DeGraff W., Mitchell J.B. Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide solutions at neutral pH. Insights into the fate and physiological effects of intermediates generated in the NO/O2 reaction. Chem. Res. Toxicol. 1994, 7:519-525.
114. Wishnok J.S., Tannenbaum S.R., Stillwell W.G., Glogowski J.A., Leaf C.D. Urinary markers for exposures to alkylating or nitrosating agents. Environ. Health Perspect. 1993, 99:155-159.
115. Yaghi A., Bend J.R., Webb C.D., Zeldin D.C., Weicker S., Mehta S., McCormack D.G. Excess nitric oxide decreases cytochrome P-450 2J4 content and P-450-dependent arachidonic acid metabolism in lungs of rats with acute pneumonia. Am. J. Physiol. Lung Cell Mol. Physiol. 2004, 286:L1260-L1267.
116. Yu J.X., Cui L., Zhang Q.Y., Chen H., Ji P., Wei H.J., Ma H.Y. Expression of NOS and HIF-1alpha in human colorectal carcinoma and implication in tumor angiogenesis. World J. Gastroenterol. 2006, 12:4660-4664.
117. Zhang Y., Hogg N. The mechanism of transmembrane S-nitrosothiol transport. Proc. Natl. Acad. Sci. U. S. A 2004, 101:7891-7896.
118. Zhou X., Espey M.G., Chen J.X., Hofseth L.J., Miranda K.M., Hussain S.P., Wink D.A., Harris C.C. Inhibitory effects of nitric oxide and nitrosative stress on dopamine-beta-hydroxylase. J. Biol. Chem. 2000, 275:21241-21246.